Center for Scientific Review; Notice of Closed Meetings, 56963-56965 [2021-22212]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 195 / Wednesday, October 13, 2021 / Notices
To deregister an establishment from
other software applications:
• Create an establishment
deregistration SPL document.
• Fill in the SetID with the SetID from
your previously accepted version.
• Enter the appropriate effective date
and version number (generally, one
number higher than the previous
submission).
• Submit.
To delist a product using CDER
Direct:
• Log into your account and open the
previously accepted version of drug
listing submission.
• Click on CREATE NEW VERSION.
This will create a copy of the file,
keeping the same SetID, but generate a
new RootID, Version Number, and
Effective date.
• Click on the product to edit the
Product Data Elements. Change the
Marketing Status from ‘‘ACTIVE’’ to
‘‘COMPLETED’’ and enter a Marketing
End Date no later than March 31, 2022.
• Save changes and click SUBMIT
SPL.
To delist a product from other
software applications:
• Open the previously accepted
version of drug listing submission.
• Create a new version with the same
SetID from your previous submission,
but generate a new RootID.
• Enter the appropriate effective date
and version number (generally, one
number higher than the previous
submission).
• Edit the product data elements.
Change the Marketing Status from
‘‘ACTIVE’’ to ‘‘COMPLETED’’ and enter
a Marketing End Date no later than
March 31, 2022.
• Save and Submit.
To request additional assistance with
deregistration and delisting, please
contact edrls@fda.hhs.gov.
jspears on DSK121TN23PROD with NOTICES1
II. Withdrawal Date
The withdrawal date for the three
guidance documents discussed in this
document is December 31, 2021.
Accordingly, firms manufacturing
alcohol under the temporary policies for
use in alcohol-based hand sanitizers and
firms and compounders preparing
alcohol-based hand sanitizers under the
temporary policies must cease
production of these products by
December 31, 2021. In addition, firms
must by March 31, 2022, cease
distribution of any remaining hand
sanitizer products that were prepared
under the temporary policies before or
on December 31, 2021. After March 31,
2022, FDA intends to cease its
temporary policy of not taking action
with regard to distribution of hand
VerDate Sep<11>2014
18:01 Oct 12, 2021
Jkt 256001
sanitizers or alcohol for use in alcoholbased hand sanitizers prepared
consistent with the circumstances
described in the withdrawn guidance
documents. The COVID–19 pandemic is
a constantly evolving situation. FDA
continues to assess these circumstances
and should the current data change to
indicate that hand sanitizer demand has
again outstripped supply prior to
December 31, 2021, FDA may alter these
dates. However, firms should assume
these dates will not change and prepare
accordingly for cessation of manufacture
and distribution of these products.
III. References
The following references marked with
an asterisk (*) are on display at the
Dockets Management Staff (HFA–305),
Food and Drug Administration, 5630
Fishers Lane, Rm. 1061, Rockville, MD
20852, 240–402–7500, and are available
for viewing by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday; they are also available
electronically at https://
www.regulations.gov. References in the
Notice without asterisks are not
available electronically at https://
www.regulations.gov because they have
copyright restrictions, but they are on
display at the Dockets Management Staff
and available for viewing at the location
and times noted above. Some may be
available at the website address, if any,
listed with the reference or such website
may provide further information on
obtaining copies. FDA has verified the
website addresses, as of the date this
document publishes in the Federal
Register, but websites are subject to
change over time.
1. Kang, J., ‘‘Retailers Couldn’t Stock Hand
Sanitizer Fast Enough. Now They Can’t
Give It Away,’’ The Wall Street Journal,
May 20, 2021, (available at https://
www.wsj.com/articles/america-is-awashin-hand-sanitizer-11621522829),
accessed August 30, 2021.
2. Dvorak, P., ‘‘Last Year, Hand Sanitizer Was
a Precious Commodity. Now They’re
Giving It Away,’’ The Washington Post,
June 24, 2021 (available at https://
www.washingtonpost.com/local/lastyear-hand-sanitizer-was-a-preciouscommodity-now-theyre-giving-it-away/
2021/06/24/351f1278-d504-11eb-9f29e9e6c9e843c6_story.html), accessed
August 30, 2021.
3. Bomey, N., ‘‘Panic Buying? Not Anymore.
Suddenly There’s a Surplus of Hand
Sanitizer,’’ USA Today, April 8, 2021
(available at https://www.usatoday.com/
story/money/2021/04/08/hand-sanitizerdeals-donations-surplus-panic-buyingpandemic/7120815002/), accessed
August 30, 2021.
4. *Letter from James Kim and Barbara
Kochanowski, ACI/CHPA, to Theresa
Michele, FDA, April 28, 2021 (available
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
56963
at https://www.regulations.gov/
comment/FDA-2020-D-1106-0164),
accessed August 30, 2021.
5. Gojo, ‘‘PURELL Brand Strongly Positioned
to Support Safe Reopening of Schools,’’
February 22, 2021 (available at https://
www.gojo.com/en/Newsroom/PressReleases/2021/PURELL-Brand-StronglyPositioned-to-Support-Safe-Reopeningof-Schools), accessed August 30, 2021.
6. *Secretary of the Department of Health and
Human Services, ‘‘Determination that a
Public Health Emergency Exists
Nationwide as the Result of the 2019
Novel Coronavirus,’’ originally issued
January 31, 2020, and subsequently
renewed (available at https://
www.phe.gov/emergency/news/
healthactions/phe/Pages/default.aspx),
accessed August 30, 2021.
Dated: October 5, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021–22108 Filed 10–12–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–20–
125: Native American Research Centers for
Health (NARCH).
Date: November 3–5, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
21–011: Expert-Driven Small Projects to
E:\FR\FM\13OCN1.SGM
13OCN1
jspears on DSK121TN23PROD with NOTICES1
56964
Federal Register / Vol. 86, No. 195 / Wednesday, October 13, 2021 / Notices
Strengthen Gabriella Miller Kids First
Discovery (R03).
Date: November 8, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Harold Laity, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–402–8254,
john.laity@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Disease Prevention and
Management, Risk Reduction and Health
Behavior Change.
Date: November 9–10, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael J. McQuestion,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114
MSC 7808, Bethesda, MD 20892, (301) 480–
1276, mike.mcquestion@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR, Shared
Instrumentation: Microscopy (S10).
Date: November 9–10, 2021.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sulagna Banerjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 612–309–2479,
sulagna.banerjee@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Cardiovascular and Surgical
Devices.
Date: November 16–17, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Willard Wilson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, 301–867–5309, willard.wilson@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Immune responses and Vaccines to
Microbial Infections.
Date: November 17–18, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
18:01 Oct 12, 2021
Jkt 256001
Contact Person: Barna Dey, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
Bethesda, MD 20892, 301–451–2796, bdey@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immunological Mechanisms in Host
Defense.
Date: November 17, 2021.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4207
MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cell Biology of Aging and Signaling
Mechanisms.
Date: November 17, 2021.
Time: 1:00 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rass M. Shayiq, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Development and Function of
Nervous System.
Date: November 17, 2021.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacek Topczewski, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 594–7574,
topczewskij2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Bacteriology.
Date: November 18–19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marci Scidmore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–435–
1149, marci.scidmore@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; BRAIN
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Initiative: Targeted BRAIN Circuits Projects
R01/R34.
Date: November 18, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Digestive
Sciences Small Business Activities.
Date: November 18–19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2106,
Bethesda, MD 20892, (301) 435–5947,
banerjees5@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biomaterials, Delivery, and
Nanotechnology.
Date: November 18–19, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892 301–435–
2902, filpuladr@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Neuro/Psychopathology, Lifespan
Development, and STEM Education.
Date: November 18–19, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia K. Ortenberg, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
MSC 7816, Bethesda, MD 20892, (301) 827–
7189, femiaee@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
HIV Coinfections and HIV Associated
Cancers Study Section.
Date: November 18, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
E:\FR\FM\13OCN1.SGM
13OCN1
Federal Register / Vol. 86, No. 195 / Wednesday, October 13, 2021 / Notices
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
Bethesda, MD 20892, 301–451–5953, tuoj@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuroscience AREA Grant Applications.
Date: November 18–19, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Peter B. Guthrie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182,
MSC 7850, Bethesda, MD 20892, (301) 435–
1239, guthriep@csr.nih.gov.
(Catalogue of Federal Domestic
Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical
Research, 93.306, 93.333, 93.337,
93.393–93.396, 93.837–93.844, 93.846–
93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 6, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–22212 Filed 10–12–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meetings
jspears on DSK121TN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; NRSA Institutional Research
Training (T32).
Date: November 10, 2021.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:01 Oct 12, 2021
Jkt 256001
Place: National Institute of Environmental
Health Sciences, Keystone Building, 530
Davis Drive, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Varsha Shukla, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, Research Triangle Park, NC
27709, (984) 287–3288, Varsha.shukla@
nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Career Development &
Pathway to Independence in Biomedical/
Clinical Research Review.
Date: November 16–17, 2021.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Sciences, Keystone Building, 530
Davis Drive, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Leroy Worth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30/
Room 3171, Research Triangle Park, NC
27709, 984–287–3340, worth@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: October 6, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–22211 Filed 10–12–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel;
Proteogenomic Tumor Analysis,
November 3, 2021, 9:30 a.m. to 7:00
p.m., National Cancer Institute at Shady
Grove, Room 7W114, 9609 Medical
Center Drive, Rockville, MD 20850
which was published in the Federal
Register on August 26, 2021, FR Doc
2021–18399, 86 FR 47652.
This notice is being amended to
change the meeting date from November
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
56965
3, 2021 to December 1, 2021. The
meeting times and location will stay the
same. The meeting is closed to the
public.
Dated: October 6, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–22213 Filed 10–12–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Member SEP.
Date: October 29, 2021.
Time: 2:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Natalia Strunnikova,
Ph.D., Scientific Review Officer, National
Institutes of Health, National Institute of
Neurological Disorders and Stroke, 6001
Executive Blvd., Suite 3208, Rockville, MD
20852, (301) 496–3755, natalia.strunnikova@
nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Clinical Trials and
Comparative Effectiveness Studies in
Neurology.
Date: November 1–2, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 86, Number 195 (Wednesday, October 13, 2021)]
[Notices]
[Pages 56963-56965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22212]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-20-125: Native American Research Centers for Health
(NARCH).
Date: November 3-5, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-RM-21-011: Expert-Driven Small Projects to
[[Page 56964]]
Strengthen Gabriella Miller Kids First Discovery (R03).
Date: November 8, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Harold Laity, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301-402-8254, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Disease Prevention and Management, Risk
Reduction and Health Behavior Change.
Date: November 9-10, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael J. McQuestion, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114 MSC 7808, Bethesda, MD
20892, (301) 480-1276, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR, Shared Instrumentation: Microscopy (S10).
Date: November 9-10, 2021.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sulagna Banerjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 612-309-2479, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Cardiovascular and Surgical Devices.
Date: November 16-17, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Willard Wilson, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20817, 301-867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Immune responses and Vaccines to Microbial
Infections.
Date: November 17-18, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barna Dey, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3184, Bethesda, MD 20892, 301-451-2796,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Immunological Mechanisms in Host Defense.
Date: November 17, 2021.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4207 MSC 7812, Bethesda, MD 20892, (301) 435-
1238, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cell Biology of Aging and Signaling
Mechanisms.
Date: November 17, 2021.
Time: 1:00 p.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rass M. Shayiq, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD
20892, (301) 435-2359, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Development and Function of Nervous System.
Date: November 17, 2021.
Time: 12:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacek Topczewski, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1, Bethesda, MD 20892, (301)
594-7574, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Bacteriology.
Date: November 18-19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marci Scidmore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD
20892, 301-435-1149, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; BRAIN Initiative: Targeted BRAIN Circuits Projects R01/R34.
Date: November 18, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Digestive Sciences Small Business Activities.
Date: November 18-19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2106, Bethesda, MD 20892, (301)
435-5947, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Biomaterials, Delivery, and Nanotechnology.
Date: November 18-19, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Filpula, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 20892 301-435-
2902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Neuro/Psychopathology, Lifespan Development,
and STEM Education.
Date: November 18-19, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elia K. Ortenberg, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108, MSC 7816, Bethesda, MD
20892, (301) 827-7189, [email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group; HIV Coinfections and HIV Associated Cancers
Study Section.
Date: November 18, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 56965]]
Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3196, Bethesda, MD 20892, 301-451-5953,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuroscience AREA Grant Applications.
Date: November 18-19, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Peter B. Guthrie, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4182, MSC 7850, Bethesda, MD
20892, (301) 435-1239, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 6, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-22212 Filed 10-12-21; 8:45 am]
BILLING CODE 4140-01-P
